Approval · Notice of Compliance 1972 · 1999
LOSEC: Notice of Compliance 1972
Issued December 2, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1972
- Date
- December 2, 1999
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of dyspepsia
- Therapeutic class
- H+, k+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOSEC | Not yet assigned | — |
Medicinal ingredients
- OMEPRAZOLE MAGNESIUM 10 MG per TAB
- OMEPRAZOLE MAGNESIUM 20 MG per TAB